格列齐特 T1527

Product Introduction
Bioactivity


英文名: Gliclazide

描述: Gliclazide (SE1702) 是一种有效的全细胞的 β 细胞 ATP 敏感型钾流阻断剂，IC50为 184 nM，用作降糖药。

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度: Ethanol : < 1 mg/mL (insoluble or slightly soluble)
H2O : < 1 mg/mL (insoluble or slightly soluble)
DMSO : 60 mg/mL (185.5 mM)


关键字: KcsA | Potassium Channel | Inhibitor | S-1702 | inhibit | S 1702 | SE 1702 | SE-1702 | Gliclazide

相关产品: VU0134992 hydrochloride | Rosuvastatin | Cromolyn sodium | Slotoxin | NS6180 | Pantoprazole Sodium Hydrate | Pandinotoxin Kα | Quinidine hydrochloride monohydrate | Bupivacaine hydrochloride monohydrate | Tetraethylammonium bromide

相关库: Drug Repurposing Compound Library | FDA-Approved & Pharmacopeia Drug Library | Anti-Cancer Compound Library | Anti-Cancer Drug Library | Membrane Protein-targeted Compound Library | Anti-Cancer Clinical Compound Library | Inhibitor Library | Anti-Diabetic Compound Library | Anti-Cancer Approved Drug Library | Orally Active Compound Library

格列齐特 T1527信息由TargetMol中国为您提供，如您想了解更多关于格列齐特 T1527报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途